Cargando…

L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine

Virus-like particles (VLPs) derived from human papillomavirus (HPV) L1 capsid proteins were used for HPV quadrivalent recombinant vaccine. The HPV quadrivalent vaccine is administrated in a 3-dose regimen of initial injection followed by subsequent doses at 2 and 6 months to prevent cervical cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akuzum, Begum, Kim, Sinae, Nguyen, Tam Thanh, Hong, Jeawoo, Lee, Siyoung, Kim, Eunhye, Kim, Joohee, Choi, Yeook, Jhun, Hyunjhung, Lee, Youngmin, Kim, Hyunwoo, Sohn, Dong Hyun, Kim, Soohyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026689/ https://www.ncbi.nlm.nih.gov/pubmed/29984037 http://dx.doi.org/10.4110/in.2018.18.e19

Ejemplares similares

Structural Characteristics of Seven IL-32 Variants
por: Sohn, Dong Hyun, et al.
Publicado: (2019)

Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6
por: Kim, Hyunwoo, et al.
Publicado: (2016)

IL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells
por: Lee, Siyoung, et al.
Publicado: (2017)

Species Specific Antiviral Activity of Porcine Interferon-α8 (IFNα8)
por: Kim, Eunhye, et al.
Publicado: (2017)

Dendritic Cell Dysfunction in Patients with End-stage Renal Disease
por: Kim, Ji Ung, et al.
Publicado: (2017)

A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
por: Shim, Saerok, et al.
Publicado: (2022)

Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity
por: Shim, Saerok, et al.
Publicado: (2022)

Role of Dendritic Cell in Diabetic Nephropathy
por: Kim, Hyunwoo, et al.
Publicado: (2021)

Proinsulin Shares a Motif with Interleukin-1α (IL-1α) and Induces Inflammatory Cytokine via Interleukin-1 Receptor 1
por: Lee, Siyoung, et al.
Publicado: (2016)

Ongoing inadequacy of quadrivalent HPV vaccine safety studies
por: Little, Deirdre T, et al.
Publicado: (2020)

Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine
por: Miller, Cheryl N., et al.
Publicado: (2021)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene
por: Kim, Sinae, et al.
Publicado: (2020)

Early Direct and Indirect Impact of Quadrivalent HPV (4HPV) Vaccine on Genital Warts: a Systematic Review
por: Mariani, Luciano, et al.
Publicado: (2015)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues
por: Kim, Sinae, et al.
Publicado: (2021)

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
por: Tjon Pian Gi, Robin E. A., et al.
Publicado: (2016)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)

Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance
por: Gomes, Jéssica Menezes, et al.
Publicado: (2020)

A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination
por: Batmunkh, Tsetsegsaihan, et al.
Publicado: (2020)

Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
por: Hong, Jaewoo, et al.
Publicado: (2021)

Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials
por: Goldstone, Stephen E.
Publicado: (2023)

Sequencing analysis of HPV-other type on an HPV DNA chip
por: Kim, Min-Jeong, et al.
Publicado: (2018)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
por: Lukács, Anita, et al.
Publicado: (2020)

SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
por: Jhun, Hyunjhung, et al.
Publicado: (2021)

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions
por: Paz-Zulueta, María, et al.
Publicado: (2018)

COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2
por: Hisham, Yasmin, et al.
Publicado: (2023)

Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada
por: Righolt, Christiaan H., et al.
Publicado: (2022)

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial
por: Pinto, Ligia A., et al.
Publicado: (2016)

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
por: Sankaranarayanan, Rengaswamy, et al.
Publicado: (2016)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection
por: Kim, Jinhee, et al.
Publicado: (2022)

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran
por: Khatibi, Mohsen, et al.
Publicado: (2014)

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2015)

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
por: Maldonado, Ivette, et al.
Publicado: (2022)

Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
por: Joshi, Smita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_52opjua3foc3b6pkue7ff0j1um